Kim T W, Kim D M
Department of Ophthalmology, Seoul National University Hospital, Korea.
Br J Ophthalmol. 1997 Dec;81(12):1070-2. doi: 10.1136/bjo.81.12.1070.
To examine the effects of 0.5% apraclonidine on optic nerve head (ONH) and peripapillary retinal blood flow by scanning laser Doppler flowmetry (SLDF).
ONH and peripapillary retinal blood flow of 17 healthy subjects were measured by SLDF before and 1 hour and 3 hours after unilateral administration of 0.5% apraclonidine. The fellow eyes were treated with balanced salt solution and the examiners were masked as to which eye was treated with apraclonidine. On each occasion, three scans were obtained and haemodynamic variables (volume, flow, and velocity) were analysed at eight locations, four in the neural rim and four in the peripapillary retina, avoiding ophthalmoscopically visible vessels. The statistical significance of changes from the baseline value of variables and the differences in the measured quantities between apraclonidine treated eyes and fellow eyes at each time point were evaluated using Wilcoxon signed rank test.
The intraocular pressure was reduced significantly in apraclonidine treated eyes by 15.0% (p = 0.001) at 1 hour and 30.0% (p = 0.000) at 3 hours after administration. In the volume, flow, or velocity of ONH and peripapillary retinal blood flow, there were no significant changes from the baseline values at 1 hour and 3 hours after apraclonidine administration in either apraclonidine treated eyes (p > 0.4) or fellow eyes (p > 0.2). Also, no significant differences were found in the measured quantities between apraclonidine treated eyes and fellow eyes at each time point (p > 0.1).
A single dose of topical apraclonidine 0.5% in healthy subjects does not have adverse effects on the ONH and peripapillary retinal blood flow.
通过扫描激光多普勒血流仪(SLDF)检测0.5%阿可乐定对视神经乳头(ONH)和视乳头周围视网膜血流的影响。
对17名健康受试者,在单侧给予0.5%阿可乐定前、给药后1小时和3小时,用SLDF测量ONH和视乳头周围视网膜血流。对侧眼用平衡盐溶液处理,检查者不知道哪只眼接受了阿可乐定治疗。每次测量时,获取三次扫描图像,并在八个位置分析血流动力学变量(体积、流量和速度),其中四个位于神经纤维层,四个位于视乳头周围视网膜,避开检眼镜可见的血管。使用Wilcoxon符号秩检验评估变量相对于基线值变化的统计学显著性,以及每个时间点阿可乐定治疗眼与对侧眼测量量的差异。
给药后1小时,阿可乐定治疗眼的眼压显著降低15.0%(p = 0.001),3小时时降低30.0%(p = 0.000)。在阿可乐定治疗眼(p > 0.4)或对侧眼(p > 0.2)中,阿可乐定给药后1小时和3小时,ONH和视乳头周围视网膜血流的体积、流量或速度与基线值相比均无显著变化。而且,每个时间点阿可乐定治疗眼与对侧眼的测量量之间也未发现显著差异(p > 0.1)。
健康受试者单次局部应用0.5%阿可乐定对视神经乳头和视乳头周围视网膜血流无不良影响。